Septodont, the leading global manufacturer of local anaesthetics in dentistry, is pleased to announce that it has made a strategic investment in U.S.-based Balanced Pharma, a dentist-founded pharmaceutical company with a focus on improved patient comfort and safety.
Balanced Pharma’s drugs currently in development are intended to improve upon current dental anesthetic drugs with elegant design solutions that retain the standard cartridge, safety & efficacy profile and shelf-life.
This investment underscores Septodont’s commitment to accelerating innovation and delivering benefits to patients and dentists without changing the means of administering anesthesia.
As a recognized authority in dental anesthesia, Septodont is uniquely positioned to partner with Balanced Pharma and help dental practices to deliver superior patient experiences.
Founded in 1932, Septodont aims to enhance lives by providing safe and effective healthcare solutions and to provide its customers with dental products and services that are unsurpassed in meeting their expectations for quality and performance. The global healthcare solutions provider, which currently holds the largest market share in local dental anaesthetics, consistently pursues innovation as it looks to provide dentists with more tools to enhance the patient comfort.
Sign up now and get an exclusive access to: